regeneron semaglutide (REGN) Highlights Benefits of and Trevogrumab in Obesity Management Semaglutide 30mg Research Peptide |

Figure 11 shows how semaglutide decreased measures of systemic inflammation following lipopolysaccharide challenge (111)

When a decision is to be made on whether someone should get started on [medication] or not, so I feel like this [study] will be very helpful concerning those discussions. We are building evidence that hopefully can be built into prediction models to help patients estimate, based on their individual circumstances, what is the most likely range of weight reduction given their persistence, BMI, sex, medication they are about to start at the time of decision-making on which GLP-1 medication to choose, or whether to choose pharmacotherapy or another modality for the treatment of obesity, Gasoyan said

Jin, H., Li, M., Jeong, E., Castro-Martinez, F

When the medication stops, appetite returns